Načítá se...
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Small-molecule inhibitor of apoptosis (IAP) antagonists, called Smac mimetic compounds (SMCs), sensitize tumours to TNF-α-induced killing while simultaneously blocking TNF-α growth-promoting activities. SMCs also regulate several immunomodulatory properties within immune cells. We report that SMCs s...
Uloženo v:
Vydáno v: | Nat Commun |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Nature Publishing Group
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330852/ https://ncbi.nlm.nih.gov/pubmed/28198370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms14278 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|